Export

Bendamustine
Essential medicine status
General description
Bendamustine is a antineoplastic alkylating agent, used in the treatment of chronic lymphocytic leukaemia and follicular lymphoma.
INN
Bendamustine
Medicine type
Chemical agent
EML status history
Therapeutic equivalent for
Wikipedia
Recommendations
Section
Cytotoxic medicines
  • Parenteral > General injections > unspecified: 45 mg per 0.5 mL; 180 mg per 2 mL